Literature DB >> 8288563

Identification and characterization of a novel tyrosine kinase from megakaryocytes.

B D Bennett1, S Cowley, S Jiang, R London, B Deng, J Grabarek, J E Groopman, D V Goeddel, H Avraham.   

Abstract

Protein-tyrosine kinases play pivotal roles in cell signal transduction. We have isolated a cDNA clone encoding a novel human intracytoplasmic tyrosine kinase, termed matk (megakaryocyte-associated tyrosine kinase). Expression of matk mRNA was predominantly found in cells of megakaryocytic lineage. The matk cDNA clone encodes a polypeptide of 527 amino acids and has closest sequence similarity to the csk tyrosine kinase. Sequence comparisons also indicate that matk contains src homology region 2 and 3 domains but lacks the NH2-terminal myristylation signal, the negative regulatory tyrosine (Tyr-527), and the autophosphorylation site (Tyr-416) corresponding to those found in src. Antibodies raised against the NH2 terminus of matk immunoprecipitated a 60-kDa protein from the CMK human megakaryocyte cell line. Expression of matk mRNA was up-regulated in megakaryocytic cells induced to differentiate by the phorbol ester. Based on its restriction in expression and its modulation during in vitro differentiation, it is likely that matk participates in signal transduction during megakaryocytopoiesis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8288563

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

1.  Effect of estrogen on expression of prohibitin in white adipose tissue and liver of diet-induced obese rats.

Authors:  Minji Choi; Harmesh N Chaudhari; Young Rae Ji; Zae Young Ryoo; Sang Woo Kim; Jong Won Yun
Journal:  Mol Cell Biochem       Date:  2015-06-06       Impact factor: 3.396

Review 2.  Role of tyrosine kinases in lymphocyte activation: targets for drug intervention.

Authors:  J H Hanke; B A Pollok; P S Changelian
Journal:  Inflamm Res       Date:  1995-09       Impact factor: 4.575

3.  Translocation of the Csk homologous kinase (Chk/Hyl) controls activity of CD36-anchored Lyn tyrosine kinase in thrombin-stimulated platelets.

Authors:  A Hirao; I Hamaguchi; T Suda; N Yamaguchi
Journal:  EMBO J       Date:  1997-05-01       Impact factor: 11.598

Review 4.  Targeting allosteric disulphide bonds in cancer.

Authors:  Philip J Hogg
Journal:  Nat Rev Cancer       Date:  2013-05-10       Impact factor: 60.716

5.  Identification of csk tyrosine phosphorylation sites and a tyrosine residue important for kinase domain structure.

Authors:  V Joukov; M Vihinen; S Vainikka; J M Sowadski; K Alitalo; M Bergman
Journal:  Biochem J       Date:  1997-03-15       Impact factor: 3.857

6.  IGF-I stimulates cooperative interaction between the IGF-I receptor and CSK homologous kinase that regulates SHPS-1 phosphorylation in vascular smooth muscle cells.

Authors:  Yashwanth Radhakrishnan; Xinchun Shen; Laura A Maile; Gang Xi; David R Clemmons
Journal:  Mol Endocrinol       Date:  2011-07-28

7.  Mutational analysis of Lck in CD45-negative T cells: dominant role of tyrosine 394 phosphorylation in kinase activity.

Authors:  U D'Oro; K Sakaguchi; E Appella; J D Ashwell
Journal:  Mol Cell Biol       Date:  1996-09       Impact factor: 4.272

8.  The nonreceptor protein-tyrosine kinase CSK complexes directly with the GTPase-activating protein-associated p62 protein in cells expressing v-Src or activated c-Src.

Authors:  K Neet; T Hunter
Journal:  Mol Cell Biol       Date:  1995-09       Impact factor: 4.272

9.  Cloning and characterization of Lnk, a signal transduction protein that links T-cell receptor activation signal to phospholipase C gamma 1, Grb2, and phosphatidylinositol 3-kinase.

Authors:  X Huang; Y Li; K Tanaka; K G Moore; J I Hayashi
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-05       Impact factor: 11.205

10.  Csk suppression of Src involves movement of Csk to sites of Src activity.

Authors:  B W Howell; J A Cooper
Journal:  Mol Cell Biol       Date:  1994-08       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.